Incyte to Present at Upcoming Investor Conferences

Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of November:

  • Guggenheim Annual Healthcare Innovation Conference on Monday, November 10, 2025 at 10:00 am (EST)
  • Jefferies Global Healthcare Conference (London) on Tuesday, November 18, 2025 at 11:00 am (GMT)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.42
+0.07 (0.03%)
AAPL  272.27
-1.40 (-0.51%)
AMD  213.94
+0.51 (0.24%)
BAC  55.72
+0.45 (0.81%)
GOOG  308.52
-0.09 (-0.03%)
META  660.85
+2.08 (0.32%)
MSFT  484.81
-1.11 (-0.23%)
NVDA  183.36
+2.37 (1.31%)
ORCL  196.67
+4.70 (2.45%)
TSLA  488.36
+7.16 (1.49%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.